Finance
Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024
BEIJING,Dec. 17,2024-- Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd. (Pien Tze Huang),a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing,was selected as one of China\
Hyundai Mobis Tackles Electric Vehicle Battery Overheating with its New Material Technology
SEOUL,South Korea,Dec. 18,2024-- HyundaiMobis (KRX 012330) announced on 18th that it has developed a new battery cell cooling material to prevent battery overheating during ultra-fast charging of ele
Wondershare Unveils Recoverit 13.5: Introducing Enhanced Compatibility and More Efficient Data Recovery Solutions
VANCOUVER,BC,Dec. 18,2024-- Wondershare,a global leader in innovative software solutions,proudly announces the launch of Recoverit 13.5,the latest iteration of its flagship data recovery software. The
COSRX's New Launch Dominates Amazon US Hot New Releases
Advanced Snail Mucin Glass Glow Hydrogel Mask Takes #1 Spot in Beauty and Personal Care NEW YORK,Dec. 18,2024-- Global skincare brand COSRX has once again taken the skincare industry by storm,with its
Global Times: Tears, triumphs and titles: Oscar reflects on eight years with Chinese club Shanghai Port
BEIJING,Dec. 10,2024-- After nearly eight memorable years in China,Brazilian footballer Oscar dos SantosEmboaba Junior,commonly known as Oscar,is contemplating whether to stay as his contract with Chi
APAC Hiring Intentions Hold Steady as Employers Maintain Measured Outlook
The Net Employment Outlook for Q1 2025 in Asia Pacific is 27%,this is unchanged from Q4,and down 3% compared to Q1 2024
Experience New Stay in Hakuba Village at Abest's "RYOKAN SUI" to Immerse in Ultimate "Wa-modern" Gateway
KOBE,Japan,Dec. 10,2024-- Hakuba Ryujin Onsen in Hakuba Village,Nagano,operated by Abest Corporation headquartered in Kobe city,Hyogo,will reopen as "Hakuba Ryujin Onsen RYOKAN SUI" in mid-D
Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL
ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med
Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax
ROCKVILLE,Md. andSUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet medi
CJ 4DPLEX and EVT Expand 4DX Footprint in Australia with Three New Theaters
Castle Hill and Innaloo in Australia set to open in time for Christmas 2024 HOLLYWOOD,Calif.,Dec. 11,2024-- CJ 4DPLEX,the world\'s leading producer of premium film formats and cinema technologies,and